FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,245 KRW | +0.90% | -1.75% | -17.92% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,245 KRW | +0.90% | -1.75% | 54.69M | ||
1,329 KRW | +5.39% | +10.20% | 66.71M | ||
1st Jan change | Capi. | |
---|---|---|
-17.92% | 54.69M | |
+17.41% | 7.1B | |
-11.40% | 1.89B | |
-5.95% | 1.26B | |
-15.28% | 1.09B | |
-43.34% | 543M | |
-5.86% | 519M | |
-33.29% | 488M | |
+13.16% | 455M | |
-32.35% | 378M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.